Amphastar Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Amphastar Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amphastar Pharmaceuticals Inc
Rating: 2.397694375
Author: Trendlyne DVM scores

Mid-range Performer

about

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

25.92 -0.22 (-0.84%)

31.17% Fall from 52W High

269.5K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Medium Financial Strength

44.4 / 100

Affordable Valuation

56.2 / 100

Technically Neutral

46.8 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 22%

7 analysts

Amphastar Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amphastar Pharma Inc Live Stock Price Today, Share Analysis and Chart

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

31.17% Fall from 52W High

SWOT Analysis

Amphastar Pharma Inc Live Price Chart